REFERENCES
1. Angheloiu GO, Gugiu GB, Ruse C, Pandey R, Dasari RR, Whatling C. Ticagrelor removal from human blood. JACC Basic Transl Sci 2017;2:135-45.
2. Friesecke S, Stecher SS, Gross S, Felix SB, Nierhaus A. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J Artif Organs 2017;20:252-9.
3. Kogelmann K, Jarczak D, Scheller M, Drüner M. Hemoadsorption by CytoSorb in septic patients: a case series. Crit Care 2017;21:74.
4. Ankawi G, Xie Y, Yang B, Xie Y, Xie P, Ronco C. What have we learned about the use of Cytosorb adsorption columns? Blood Purif 2019;48:196-202.
5. Day JRS, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg 2005;3:129-40.
6. Hawkes AL, Nowak M, Bidstrup B, Speare R. Outcomes of coronary artery bypass graft surgery. Vasc Health Risk Manag 2006;2:477-84.
7. Laffey JG, Boylan JF, Cheng DCH. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002;97:215-52.
8. Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNFalpha in pulmonary pathophysiology. Respir Res 2006;7:125.
9. Bakhtiary F, Moritz A, Kleine P, et al. Leukocyte depletion during cardiac surgery with extracorporeal circulation in high risk patients. Inflamm Res 2008;57:577-85.
10. Boueiz A, Hassoun PM. Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc Res 2009;77:26-34.
11. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315.
12. Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol 2017;34:332-95.
13. Hansson EC, Jidéus L, Åberg B, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J 2016;37:189-97.
15. Dobesh PP, Oestreich JH. Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety. Pharmacotherapy 2014;34:1077-90.
16. Capodanno D, Tamburino C. Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside. J Cardiovasc Transl Res 2014;7:82-90.
17. Garau I, März A, Sehner S, et al. Hemadsorption during cardiopulmonary bypass reduces interleukin 8 and tumor necrosis factor α serum levels in cardiac surgery: a randomized controlled trial. Minerva Anestesiol 2019;85:715-23.
18. Gleason TG, Argenziano M, Bavaria JE, et al. Hemoadsorption to reduce plasma-free hemoglobin during cardiac surgery: Results of REFRESH I pilot study. Sem Thorac Cardiovasc Surg 2019;31:783-93.
19. Hohn A, Baumann A, Pietroschinsky E, et al. Hemoadsorption: effective in reducing circulating fragments of the endothelial glycocalyx during cardiopulmonary bypass in patients undergoing on-pump cardiac surgery? Minerva Anestesiol 2021;87:35-42.
20. Bernardi MH, Rinoesl H, Dragosits K, et al. Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care 2016;20:96.
21. Bernardi MH, Rinoesl H, Ristl R, Weber U, Wiedemann D, Hiesmayr MJ. Hemoadsorption does not have influence on hemolysis during cardiopulmonary bypass. ASAIO J 2019;65:738-43.
22. Poli EC, Alberio L, Bauer-Doerries A, et al. Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial. Crit Care 2019;23:108.
23. Wisgrill L, Lamm C, Hell L, et al. Influence of hemoadsorption during cardiopulmonary bypass on blood vesicle count and function. J Transl Med 2020;18:202.
24. Taleska Stupica G, Sostaric M, Bozhinovska M, et al. Extracorporeal hemadsorption versus glucocorticoids during cardiopulmonary bypass: A prospective, randomized, controlled trial. Cardiovasc Ther 2020;2020:7834173.
25. Hassan K, Kannmacher J, Wohlmuth P, Budde U, Schmoeckel M, Geidel S. Cytosorb adsorption during emergency cardiac operations in patients at high risk of bleeding. Ann Thorac Surg 2019;108:45-51.
26. EuroELSO 2020 Poster Abstracts. Perfusion 2020;35:93-282. https://journals.sagepub.com/doi/pdf/10.1177/0267659120909723.
27. Hassan K, Stoeck M, Brüning T, et al. Budget impact analysis of sorbent hemadsorption during emergency cardiac surgery in ticagrelor-loaded patients. Thorac Cardiovasc Surg 2020;68:S1-S72.
28. Hassan K, Brüning T, Radtke A, et al. Low bleeding after emergency CABG using CytoSorb adsorption of ticagrelor: A 2-year clinical experience. Thorac Cardiovasc Surg 2020;68:S1-S72.
29. Javanbakht M, Trevor M, Rezaei Hemami M, et al. Ticagrelor removal by CytoSorb(®) in patients requiring emergent or urgent cardiac surgery: A UK-based cost-utility analysis. Pharmacoecon Open 2020;4:307-19.
30. Mair H, Jilek C, Haas B, Lamm P. Ticagrelor and rivaroxaban elimination with CytoSorb adsorber before urgent off-pump coronary bypass. Ann Thorac Surg 2020;110:e369-e70.
